Related Experiment Video
Updated: May 17, 2026

12:19
Imaging Intracellular Ca2+ Signals in Striatal Astrocytes from Adult Mice Using Genetically-encoded Calcium Indicators
Published on: November 19, 2014
Neurotoxins released from interferon-gamma-stimulated human astrocytes
1Kinsmen Laboratory of Neurological Research, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, Canada V6T 1Z3.
Neuroscience
|October 27, 2012
Summary
Activated astrocytes release a mix of neurotoxic factors contributing to neurodegenerative diseases. Combining anti-inflammatory treatments targeting these factors shows promise for improving therapeutic outcomes.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Astrocytes are glial cells that become activated during neurodegenerative diseases.
- Activated astrocytes release inflammatory factors that can be neurotoxic.
- Understanding these factors is crucial for developing effective treatments for neurological disorders.
Purpose of the Study:
- To identify and characterize the neurotoxic components released by activated human astrocytes.
- To assess the contribution of specific inflammatory mediators to astrocyte-conditioned medium (CM) toxicity.
- To evaluate the potential of combination anti-inflammatory therapy for neurodegenerative diseases.
Main Methods:
- Adult human astrocytes were stimulated with interferon-gamma.
- The conditioned medium (CM) was tested for toxicity against human neuroblastoma SH-SY5Y cells using lactate dehydrogenase release assay.
- Specific components like interleukin-6, proteases, oxygen-free radicals, prostaglandins, and glutamate were targeted using antibodies, inhibitors, and enzymes to assess their contribution to toxicity.
Main Results:
- Activated astrocytes release a combination of neurotoxic factors, including interleukin-6, proteases, oxygen-free radicals, prostaglandins, and glutamate.
- Targeting individual components reduced CM toxicity: interleukin-6 (22%), proteases (22%), oxygen-free radicals (15.4%), prostaglandins (14.5%), and glutamate (10.3%).
- Combined blockade of these factors reduced overall CM toxicity by 91%, indicating a synergistic effect.
Conclusions:
- Activated astrocytes secrete a cocktail of neurotoxic substances.
- Effective treatment of neurodegenerative diseases may require combination anti-inflammatory therapies targeting multiple pathways.
- This study provides a basis for developing improved therapeutic strategies for conditions like Alzheimer's, Parkinson's, and ALS.
